Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002005779 | SCV002270520 | uncertain significance | Carnitine palmitoyl transferase 1A deficiency | 2022-07-11 | criteria provided, single submitter | clinical testing | This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 605 of the CPT1A protein (p.Val605Met). This variant is present in population databases (rs747835344, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with CPT1A-related conditions. ClinVar contains an entry for this variant (Variation ID: 1484417). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV002579623 | SCV003696311 | uncertain significance | Inborn genetic diseases | 2022-02-02 | criteria provided, single submitter | clinical testing | The c.1813G>A (p.V605M) alteration is located in exon 15 (coding exon 14) of the CPT1A gene. This alteration results from a G to A substitution at nucleotide position 1813, causing the valine (V) at amino acid position 605 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |